-
Peeking Back In On Portola Pharmaceuticals
13 May 2019 12:44 GMT
… expected first-quarter report is Portola Pharmaceuticals (PTLA). Today, we revisit this … its balance sheet. Company Overview: Portola Pharmaceuticals is a biotech concern based … The Biotech Forum, The Busted IPO Forum, and The Insiders Forum …
-
Portola Pharmaceuticals Announces Retirement of CEO Bill Lis in 2018
04 Jun 2018 20:30 GMT
… , Portola completed its initial public offering, advanced multiple innovative … term growth.” About Portola Pharmaceuticals, Inc.
Portola Pharmaceuticals is a commercial … and Investor Contact:
Cara Miller
Portola Pharmaceuticals
Tel: …
-
Portola Pharmaceuticals: Bleeding Out
10 Jan 2017 14:24 GMT
Portola Pharmaceuticals (NASDAQ:PTLA) was one of … ;s most hotly anticipated biotech IPOs when it was brought public …
-
Biotech IPO Party Rages On
14 Sep 2020 16:12 GMT
… sciences companies have carried out IPOs, raising a total of … 5 billion.
With more biotech IPOs waiting in the wings, 2020 … that could cause the biotech IPO market to go south.
… prices.
In May 2020, Portola Pharmaceuticals, which sells Andexxa for excessive …
-
The Daily Biotech Pulse: Amgen Hurt By Generic Competition, Nanoviricides Confirms Working On Wuhan Virus, Arcutis IPO
31 Jan 2020 14:31 GMT
… : MNOV)
Neuronetics Inc (NASDAQ: STIM)
Portola Pharmaceuticals Inc (NASDAQ: PTLA)
REDHILL BIOPHAR … T-cell leukemia/lymphoma.
IPO
Arcutis Biotherapeutics, a biotech company … skin diseases, priced its upsized initial public offering of 9.375 million shares …
-
The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO
28 Feb 2020 12:42 GMT
… )
Plus Therapeutics Inc (NASDAQ: PSTV)
Portola Pharmaceuticals Inc (NASDAQ: PTLA)
Precigen Inc … : GLYC) (before the market open)
IPO
Passage Bio, a biotech developing …
-
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs
22 Feb 2019 18:59 GMT
… open)
Portola Pharmaceuticals Inc (NASDAQ: PTLA) (before the market open)
IPO
Kaleido Biosciences … .76 million shares in an IPO priced between $20 and $22 … under the ticker symbol KLDO.
IPO Quiet Period Expiry
INmune Bio …